FDA Approval Manufacturing Protein Reagent 
Pharmaceutical Technology
APRIL 28, 2023
The company undertook several initiatives recently to expand its business through new partnerships, expansion of existing relationships, and investment in manufacturing capacity. Initially centered on Librela®, this agreement paves the way for developing and manufacturing other molecules in the coming years. until 2026.
Drug Discovery World
DECEMBER 13, 2023
Fortis Life Sciences offers custom antibody discovery and manufacturing services for antibodies and single-domain antibodies, supporting the drug discovery market. Moreover, custom antibodies are a key reagent in companion diagnostics for these novel therapeutics.
Drug Discovery World
JUNE 14, 2023
One example we are following with anticipation are the two FDA approvals for the first gene therapies for sickle cell disease. We offer a Cell Collections training program geared to biotechs, teaching how to shorten, streamline and standardise the collection process which can help reduce costs, and scale cell manufacturing.
Expert insights. Personalized for you.
130 
Let's personalize your content